CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Business Combination, Acquired Receivables, Gross Contractual Amount
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Business Combination, Acquired Receivables, Gross Contractual Amount of $35.07 million as of 2018-04-03, per its 10-Q filed 2019-05-07.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationAcquiredReceivablesGrossContractualAmount · last filed 2019-05-07
- 2018-04-03: Business Combination, Acquired Receivables, Gross Contractual Amount $35.07M.
| Period end | Business Combination, Acquired Receivables, Gross Contractual Amount |
|---|---|
| 2018-04-03 | $35.07M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |